These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30826571)

  • 1. Angiotensin converting enzyme and neprilysin inhibition alter pain response in dexhamethasone-induced hypertensive rats.
    Aykan DA; Koca TT; Yaman S; Eser N
    Pharmacol Rep; 2019 Apr; 71(2):306-310. PubMed ID: 30826571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure.
    Dizaye K; Ali RH
    BMC Pharmacol Toxicol; 2019 May; 20(1):23. PubMed ID: 31053170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury.
    Uijl E; 't Hart DC; Roksnoer LCW; Groningen MCC; van Veghel R; Garrelds IM; de Vries R; van der Vlag J; Zietse R; Nijenhuis T; Joles JA; Hoorn EJ; Danser AHJ
    J Hypertens; 2020 Apr; 38(4):755-764. PubMed ID: 31790054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension.
    Savitha MN; Suvilesh KN; Siddesha JM; Milan Gowda MD; Choudhury M; Velmurugan D; Umashankar M; Vishwanath BS
    Peptides; 2020 Jan; 123():170180. PubMed ID: 31715212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
    Quaschning T; Hocher B; Ruhl S; Kraemer-Guth A; Tilgner J; Wanner C; Galle J
    Kidney Blood Press Res; 2006; 29(6):351-9. PubMed ID: 17139187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
    Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL
    Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
    J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Raasch W; Dominiak P; Dendorfer A
    J Hypertens; 2005 Aug; 23(8):1597-604. PubMed ID: 16003188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial responses to bradykinin after ramipril therapy in experimental hypertension.
    Hutri-Kähönen N; Pörsti I; Wu X; Tolvanen JP; Sallinen K; Kähönen M
    Pharmacol Toxicol; 1997 Oct; 81(4):190-6. PubMed ID: 9353850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
    Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension.
    Stavropoulos K; Imprialos KP; Doumas M
    J Clin Hypertens (Greenwich); 2018 Jan; 20(1):65-68. PubMed ID: 29237097
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
    Gupta S; Chattopadhyaya I; Agrawal BK; Sehajpal PK; Goel RK
    J Postgrad Med; 2015; 61(1):21-6. PubMed ID: 25511213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension.
    Alves-Lopes R; Montezano AC; Neves KB; Harvey A; Rios FJ; Skiba DS; Arendse LB; Guzik TJ; Graham D; Poglitsch M; Sturrock E; Touyz RM
    Hypertension; 2021 Sep; 78(3):604-616. PubMed ID: 34304582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance.
    Ismael MA; Talbot S; Carbonneau CL; Beauséjour CM; Couture R
    Eur J Pharmacol; 2008 Jul; 589(1-3):66-72. PubMed ID: 18555989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
    Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
    Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.